Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland.
BMC Public Health
; 20(1): 671, 2020 May 12.
Article
in En
| MEDLINE
| ID: mdl-32398057
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Uterine Cervical Dysplasia
/
Uterine Cervical Neoplasms
/
Vaccination
/
Immunization Programs
/
Papillomavirus Infections
/
Papillomavirus Vaccines
Type of study:
Incidence_studies
/
Prognostic_studies
/
Screening_studies
Limits:
Adolescent
/
Adult
/
Child
/
Female
/
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
BMC Public Health
Journal subject:
SAUDE PUBLICA
Year:
2020
Type:
Article
Affiliation country:
Switzerland